Prothrombin (PTR) Mutation Molecular Detection
Test Catalog Information
| Test Catalog Synonyms | |
| EPIC Synonyms |
FACTOR II Venous thrombosis Factor II G20210A mutation testing FACTOR 2 |
| Cerner Primary Mnemonic | zzzMGPTR |
| EPIC Display Name | Prothrombin (PTR) Mutation Molecular Detection |
| Allscripts (AEHR) Order Name | Not Orderable |
| Sunrise Clinical Manager (SCM) Order Name | Not Orderable |
| EPIC Inpatient Orderable | Yes |
| EPIC Outpatient Orderable | Yes |
| Cerner Results | |
| Clinical Info |
The prothrombin (Factor II) mutation refers to a base change from guanine (G) to adenine (A) at nucleotide position 20210 in the prothrombin gene. The G20210A mutation is associated with an elevation of prothrombin levels to about 30 percent above normal in heterozygotes and to 70 percent above normal in homozygotes. The mutation is the second most common inherited risk factor for thrombosis. In the United States, the prevalence of the mutant allele is 1.1 percent in Caucasians and Hispanics and 0.3 percent in African Americans. This mutation is present in about 2 percent of the population and in 6 percent or more of patients who present with a first venous thromboembolism (VTE). |
| Specimen Type |
Blood |
| Container |
Lavender Top Tube |
| Collection Instructions | |
| Transport Instructions | |
| Specimen Stability | |
| Methodology | |
| Days Performed | |
| Performing Laboratory |
NSLIJ Manhasset |
| CPT | |
| PDM |
5160177xx |
Desired Epic Build Prothrombin (PTR) Mutation Molecular Detection
| Cerner Primary Mnemonic: | zzzMGPTR |
| PDM | 5160177 |
| Informatics - Workgroup | Molpath inhouse |
| Synonyms * | FACTOR II Venous thrombosis Factor II G20210A mutation testing FACTOR 2 |
| Display Name * | Prothrombin (PTR) Mutation Molecular Detection |
| Order Entry Specimen Sources * | |
| Order Entry Specimen Types |
Blood
|
| Specimen Navigator Specimen Types | |
| Specimen Navigator Specimen Sources | |
| Specimen Navigator Short Name | |
| Ordering info (EPIC SmartText) | The prothrombin (Factor II) mutation refers to a base change from guanine (G) to adenine (A) at nucleotide position 20210 in the prothrombin gene. The G20210A mutation is associated with an elevation of prothrombin levels to about 30 percent above normal in heterozygotes and to 70 percent above normal in homozygotes. The mutation is the second most common inherited risk factor for thrombosis. In the United States, the prevalence of the mutant allele is 1.1 percent in Caucasians and Hispanics and 0.3 percent in African Americans. This mutation is present in about 2 percent of the population and in 6 percent or more of patients who present with a first venous thromboembolism (VTE). |
| IP Orderable | Yes |
| OP Orderable | Yes |
|
AOEs * | |
| AP AOEs | |
| Special History | No |
| Build Comments | |
| Filter * | genetics |
| Procedure Category Change | |
| Cerner Results | |
Current Actual EPIC Build as of 10/28/2024
| Procedure Id | 64734 | ||||||||||||||||||||||||||||||
| Pdm | 5160177 | ||||||||||||||||||||||||||||||
| Order Display Name | Prothrombin (PTR) Mutation Molecular Detection | ||||||||||||||||||||||||||||||
| Procedure Name | PROTHROMBIN GENE MUTATION | ||||||||||||||||||||||||||||||
| Procedure Master Number | LAB834 | ||||||||||||||||||||||||||||||
| Short Procedure Name | PROTHROMBIN GENE MUTATIO | ||||||||||||||||||||||||||||||
| Category Code | 21.0 | ||||||||||||||||||||||||||||||
| Category Code Record Name | LAB MOLECULAR DIAGNOSTICS ORDERABLES | ||||||||||||||||||||||||||||||
| Synonyms | FACTOR II VENOUS THROMBOSIS FACTOR II G20210A MUTATION TESTING FACTOR 2 | ||||||||||||||||||||||||||||||
| Clinically Active | Yes | ||||||||||||||||||||||||||||||
| Orderable | Yes | ||||||||||||||||||||||||||||||
| Performable | Yes | ||||||||||||||||||||||||||||||
| Filter Genomics | Generic Genomics Procedure | ||||||||||||||||||||||||||||||
| Reference Link Url | https://labs.northwell.edu/epic/test/64734 | ||||||||||||||||||||||||||||||
| Ordering Instructions | |||||||||||||||||||||||||||||||
| Default Specimen Type | Blood | ||||||||||||||||||||||||||||||
| Specimen Type Pick List | Blood | ||||||||||||||||||||||||||||||
| Specimen Type List | |||||||||||||||||||||||||||||||
| Op Specimen Type List | |||||||||||||||||||||||||||||||
| Specimen Source Pick List | Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous | ||||||||||||||||||||||||||||||
| Specimen Source Default - Male | Blood, Venous | ||||||||||||||||||||||||||||||
| Specimen Source Default - Female | Blood, Venous | ||||||||||||||||||||||||||||||
| Specimen Source List | Blood, Venous Blood, Central Line Blood, Arterial Blood, Capillary | ||||||||||||||||||||||||||||||
| Op Specimen Source List | |||||||||||||||||||||||||||||||
| Ip Lab Test Components For Report | HLXPTRFR | ||||||||||||||||||||||||||||||
| Op Lab Test Components For Report | HLXPTRFR | ||||||||||||||||||||||||||||||
| Order Questions | ["3048500000", "3045300170", "3045300171", "3045300173"] | ||||||||||||||||||||||||||||||
| Order Questions Record Name | NH IP PATIENT COMPLETED CONSENT NH IP HOME COLLECT DATE NH IP HOME COLLECT DAYS NH IP HOME COLLECT MEDICALLY NECESSARY | ||||||||||||||||||||||||||||||
| Inpatient Order Questions | ["3048500000", "3048500000"] | ||||||||||||||||||||||||||||||
| Inpatient Order Questions Record Name | NH IP PATIENT COMPLETED CONSENT | ||||||||||||||||||||||||||||||
| Order Specific Question Override | Yes | ||||||||||||||||||||||||||||||
| Inpatient Question Override | |||||||||||||||||||||||||||||||
| Location Restrict List Ip | |||||||||||||||||||||||||||||||
| Location Restrict List Ip Record Name | |||||||||||||||||||||||||||||||
| Location Restrict List Include Ip | |||||||||||||||||||||||||||||||
| Location Restrict List Op | |||||||||||||||||||||||||||||||
| Location Restrict List Op Record Name | |||||||||||||||||||||||||||||||
| Location Restrict List Includes Op | |||||||||||||||||||||||||||||||
| Edp Amb Order Specific Questions Record Name | NH IP PATIENT COMPLETED CONSENT | ||||||||||||||||||||||||||||||
| Edp Ip Order Specific Questions Record Name | NH IP PATIENT COMPLETED CONSENT | ||||||||||||||||||||||||||||||
| Edp Ip Specimen Source | |||||||||||||||||||||||||||||||
| Edp Op Specimen Source | |||||||||||||||||||||||||||||||
| Edp Ip Specimen Type | |||||||||||||||||||||||||||||||
| Edp Op Specimen Type | |||||||||||||||||||||||||||||||
| Derived Edp Ip Buttons S | |||||||||||||||||||||||||||||||
| Derived Edp Ip Buttons T | |||||||||||||||||||||||||||||||
| Derived Edp Op Buttons S | |||||||||||||||||||||||||||||||
| Derived Edp Op Buttons T | |||||||||||||||||||||||||||||||
| Ip Orderable | 1 | ||||||||||||||||||||||||||||||
| Op Orderable | 1 | ||||||||||||||||||||||||||||||
EPIC OP AOEs
| |||||||||||||||||||||||||||||||
EPIC IP AOEs
| |||||||||||||||||||||||||||||||
| EPIC Components (results) | |||||||||||||||||||||||||||||||